Ratings The Simply Good Foods Company

Equities

SMPL

US82900L1026

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-05 pm EDT			5-day change	1st Jan Change
36.22 ^USD	+0.98%		+0.25%	-8.54%

Jul. 01	DA Davidson Raises Price Target on Simply Good Foods to $38 From $35, Maintains Neutral Rating	MT
Jun. 27	Sector Update: Consumer Stocks Mixed in Afternoon Trading	MT

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.

Weaknesses

With a 2024 P/E ratio at 23.96 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
The average consensus view of analysts covering the stock has deteriorated over the past four months.
Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Food Processing

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
THE SIMPLY GOOD FOODS COMPANY	-8.54%	3.63B		B-
ZHEJIANG NHU COMPANY LTD.	+13.33%	8.13B		D+
BELLRING BRANDS, INC.	+9.35%	7.91B		C-
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	-19.26%	4.76B		-
BYHEALTH CO., LTD	-20.61%	3.16B		D
XIAMEN KINGDOMWAY GROUP COMPANY	-12.55%	1.2B	-	-
HERBALIFE LTD.	-26.47%	1.12B		B+
JAMIESON WELLNESS INC.	-7.63%	892M		C+
USANA HEALTH SCIENCES, INC.	-17.95%	838M		C+
SIRIO PHARMA CO., LTD.	-11.48%	761M		-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes